v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows from Operating Activities    
Net loss $ (24,128,591) $ (24,930,687)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 1,730,617 960,930
Loss on disposal of property and equipment 39,694 19,668
Noncash lease expense 886,942 684,360
Interest on finance leases 1,928
Loss on marketable securities 71,732
Credit loss expense 39,956 55,222
Loss on write-off of related party receivables 110,000
Contract modification - related party 280,545
Share-based compensation 10,280
Bargain purchase gain (2,068,047)
Write-off of demonstration equipment 441,624
Interest expense paid in equity shares 12,269,120
Accrued interest on notes payable 511,568 803,030
Non-cash royalty income (27,746) (48,668)
Amortization of original issue discounts on notes payable 427,083 29,167
Loan origination costs 25,000 5,000
Receipt of SOL from staking (47,704)
Non-cash transaction fees 10,285
Unrealized loss on digital assets 1,225,705
Loss on exercise of warrant liabilities 4,651,745 15,722,096
Changes in fair value of warrant liability (85,820) 8,928,275
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables 1,929,565 (1,534,474)
Trade receivables - related party 37,261 87,116
Inventory (1,152,509) 1,162,286
Contract assets (17,138) 387,056
Prepaid expenses and other current assets (173,203) (98,976)
Other assets 14,868 125,035
Accounts payable (385,535) 295,378
Sales tax payable (15,952) (58,449)
Operating lease liabilities (906,596) (692,804)
Deposits from customers 161,589 (146,744)
Accrued expenses (264,430) 60,159
Contract liabilities 180,922 1,455,386
Deferred revenue (686,802) (135,687)
Income taxes payable 292,337 (24,582)
Other liabilities 517 10,864
Net cash (used in)/provided by operating activities (4,900,015) 3,410,782
Cash Flows from Investing Activities    
Purchase of property and equipment (966,783) (1,435,743)
Proceeds from sale of property and equipment 17,133 13,511
Royalties on related party revenues 40,000 40,000
Purchase of marketable securities (9,732,488)
Proceeds from sale of marketable securities 5,958,849
Acquisitions, net of cash acquired (7,594,695)
Investment in digital assets (1,000,567)
Investment in MasterpieceVR (100,000)
Net cash used by investing activities (13,278,551) (1,482,232)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 14,694,166 23,424,024
Payments on revolving line of credit (15,873,476) (24,509,177)
Payments on debt (419,597) (985,212)
Financing lease liabilities (27,587)
Payments on Paycheck Protection Program Loans (50,628)
Proceeds on Loan from CEO 200,000
Proceeds on bank loans 500,000
Proceeds from notes payable 7,000,000 1,307,354
Proceeds from warrant exercises 5,787,831
Proceeds from offerings 10,000,000 1,463,550
Expenses on offerings (9,473) (232,100)
Net cash provided by financing activities 21,151,864 1,117,811
Effect of currency translation (18,599) (321,394)
Net increase in cash, cash equivalents, and restricted cash 2,954,699 2,724,967
Cash, cash equivalents, and restricted cash at beginning of period 6,347,041 5,420,392
Total cash, cash equivalents, and restricted cash 9,301,740 8,145,359
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 7,972,128 7,032,530
Restricted cash 1,329,612 1,112,829
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 562,036 1,777,081
Cash paid during the period for income taxes, net of refunds 78,305 237,943
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay notes payable 21,211,561
Noncash dividends 136 252
Financing of Building Purchase 3,920,000
Financing of Acquisitions 600,000
Noncash recognition of new leases 983,114 720,104
Series A Warrant Exercises 211,098 21,515,777
Series B Warrant Exercises $ 16,011,703 $ 1,386,169

Source